Siao-Yi Wang, MD, PhD

My research interests are primarily in adoptive T-cell therapy (ACT) for solid tumors. While ACT has demonstrated impressive results in hematologic malignancies, success has been limited in solid tumors. I am investigating ways to improve ACT through novel methods of generating genetically-modified cells and through modulating the tumor immune microenvironment.